Devyser Diagnostics AB (publ) (DVYSR) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Divisor Diagnostics Q4 Report 2025 presentation. During the Q&A session, participants are able to ask questions by dialing pound key 5 on their telephone keypad. Now, I will hand the conference over to the speakers. CEO Jan Wallstrom, CFO Sabina Berlin, and CCO Thijs Kipling, please go ahead. Good day and welcome to the Devizor Q4 2025 earnings call. I'm Jan Wallström, CEO of Devizor, and would like to thank you everyone for joining our call today. Today's presenters and on the call today we have, in addition to myself, also our CFO Sabina Berlin and our CCO Thijs Kipling. I will start with a short summary of our quarterly result and then recap our recent activities that resulted in a record profitable quarter as well as a record sales quarter. I will give you an update on the recent product launches and present some additional highlights from the quarter before handing over to Sabine now for a more detailed review of our financial results in Q4 2025 and then to Thijs for an update on our recent commercial activities. As headlines, I would say that we have started a new journey in the beginning of this year and focused the company towards profitable growth. For the full year, we now deliver EBIT profitability and we will continue to focus on costs at the same time as we drive to growth at a high pace. Looking at the fourth quarter highlights, we are turning the company around on a path to profitability. We had another record quarter based on revenue with 72 million in sales, representing a growth of 20% compared to Q4 last year in local currencies. In important currencies, it was lower as we are facing currency headwinds. Gross margins came in at 79%. It's a disappointment and we will continue to work on improving the margins in 2026. What we are most sati...